BMY•benzinga•
Bristol-Myers Squibb To $87? Here Are 5 Other Price Target Changes For Monday
Summary
Atlantic Equities raised the price target on Bristol-Myers Squibb Company (NYSE: BMY) from $83 to $87. Atlantic Equities analyst Steve Chesney maintained an Overweight rating on the stock. Bristol-Myers Squibb shares rose 6.3% to $74.60 in pre-market trading.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 12, 2022 by benzinga